Categorization of overall responses based on the EUMNET and IWG-MRT criteria
| . | Intention to treat (n = 30) . | Per-protocol (n = 25) . |
|---|---|---|
| EUMNET criteria | ||
| Complete response | 0 (0.0) | 0 (0.0) |
| Major response | 8 (26.7) | 8 (32.0) |
| Moderate response | 7 (23.3) | 5 (20.0) |
| Minor response | 3 (10.0) | 2 (8.0) |
| No response | 12 (40.0) | 10 (40.0) |
| Progression | 0 (0.0) | 0 (0.0) |
| IWG-MRT criteria | ||
| Complete response | 0 (0.0) | 0 (0.0) |
| Partial remission | 1 (3.3) | 1 (4.0) |
| Clinical improvement | 6 (20.0) | 5 (20.0) |
| Progressive disease | 0 (0.0) | 0 (0.0) |
| Stable disease | 23 (76.7) | 19 (76.0) |
| Relapse | 0 (0.0) | 0 (0.0) |
| . | Intention to treat (n = 30) . | Per-protocol (n = 25) . |
|---|---|---|
| EUMNET criteria | ||
| Complete response | 0 (0.0) | 0 (0.0) |
| Major response | 8 (26.7) | 8 (32.0) |
| Moderate response | 7 (23.3) | 5 (20.0) |
| Minor response | 3 (10.0) | 2 (8.0) |
| No response | 12 (40.0) | 10 (40.0) |
| Progression | 0 (0.0) | 0 (0.0) |
| IWG-MRT criteria | ||
| Complete response | 0 (0.0) | 0 (0.0) |
| Partial remission | 1 (3.3) | 1 (4.0) |
| Clinical improvement | 6 (20.0) | 5 (20.0) |
| Progressive disease | 0 (0.0) | 0 (0.0) |
| Stable disease | 23 (76.7) | 19 (76.0) |
| Relapse | 0 (0.0) | 0 (0.0) |
EUMNET indicates European Network for Myelofibrosis; and IWG-MRT, International Working Group for Myelofibrosis Research and Treatment.